CRISPR Therapeutics Vertex Pharmaceuticals: Better Buy in 2026
Investors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
Value investing can be a powerful strategy for new investors. Learn key tips to enhance your investment skills and achieve better returns.
28,096 articlesInvestors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
Intel stock looks beaten in the near term, but long-term possibilities remain. This guide breaks down the factors tha...
A notable stake by Starboard Value in Fluor hints at renewed confidence in the industrial cycle. This article explain...
Berkshire Hathaway's big Alphabet stake marks a rare foray into technology by Warren Buffett. This article breaks dow...
Stran’s Q1 2026 earnings reveal a mix of steady demand and evolving margins. This article breaks down the numbers, of...
Bill Gates manages a massive charitable portfolio with a striking concentration: about 30% of its value sits in a sin...
On March 2, energy and defense names spearheaded gains as oil jumped, while travel and leisure stocks softened. This ...
Vuzix is aiming to turn AR glasses into practical frontline tools. This guide breaks down what vuzix (vuzi) 2026 earn...
A major move by a wealth manager can ripple through markets and tax strategies. Discover what truewealth exits $12.8 ...
A prominent investor takes a sizable stake in BrightSpring Health Services, sparking renewed attention on BTSG stock....
Robert Kiyosaki says he bought more BTC, doubling down on a view that bitcoin could eventually outperform gold amid m...
A close look at the stock most likely to join the $1 trillion club soon. Learn the catalysts, how to buy, and risk co...